1E Therapeutics Patents – Insights & Stats (Updated 2024)
1E Therapeutics has a total of 32 patents globally, out of which 2 have been granted. Of these 32 patents, more than 84% patents are active. United States of America…
1E Therapeutics has a total of 32 patents globally, out of which 2 have been granted. Of these 32 patents, more than 84% patents are active. United States of America…
Abbott has expanded its presence across various industries through strategic acquisitions and subsidiaries. By acquiring companies in sectors like medical devices, diagnostics, and nutrition, Abbott has strengthened its portfolio and…
Pfizer has grown its presence in various industries through smart acquisitions and subsidiaries. These acquisitions have allowed Pfizer to strengthen its product offerings and services, diversify its portfolio, and enhance…
Hangzhou Pushai Pharmaceutical has a total of 28 patents globally, out of which 1 have been granted. Of these 28 patents, more than 2% patents are active. China is where…
Innovative Cellular Therapeutics has a total of 20 patents globally, out of which 7 have been granted. Of these 20 patents, more than 55% patents are active. China is where…
Impact Therapeutics has a total of 222 patents globally, out of which 96 have been granted. Of these 222 patents, more than 74% patents are active. China is where Impact…
HeiLongJiang ZBD Pharmaceutical has a total of 209 patents globally, out of which 121 have been granted. Of these 209 patents, more than 56% patents are active. China is where…
Hightide has a total of 181 patents globally, out of which 86 have been granted. Of these 181 patents, more than 70% patents are active. The United States of America…
Penwest Pharmaceuticals has a total of 234 patents globally, out of which 105 have been granted. Of these 234 patents, more than 1% patents are active. Europe (EPO) is where…
Intas Pharmaceuticals has a total of 571 patents globally, out of which 146 have been granted. Of these 571 patents, more than 77% patents are active. India is where Intas…